A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study. (Q46528728)
Jump to navigation
Jump to search
scientific article published on 21 June 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study. |
scientific article published on 21 June 2008 |
Statements
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study (English)
Dominick J Angiolillo
Shinya Goto
Mohammed Aslam
Bhaloo Desai
Ronald K Charlton
Yoshie Suzuki
Lyndon C Box
Steven B Shoemaker
Martin M Zenni
Luis A Guzman
Theodore A Bass